Zimmer Biomet has released a clinical compendium demonstrating evidence of the BioBoost Effect. This novel, reproducible biological effect follows the placement of Trabecular Metal Dental Implants and evidences the acceleration of bone growth, vascularization, and wound healing.
Several clinical publications demonstrate a multiplication of naturally occurring growth factors that deliver faster healing and earlier bone formation than traditional implants, Zimmer Biomet reports. The discovery of the effect has expanded treatment options for dental patients who, until recently, may not have been viable candidates for dental implant therapy, the company adds.
“The Trabecular Metal Implant in rapid recovery protocol has been a game-changer for our practice,” said Jason Kennedy, DMD. “We can take a patient from an edentulous state to a final restoration in two weeks’ time.”
The compendium summarizes highlights from 30 clinical publications, documenting immediate and long-term success in rapid recovery, high risk, and revision therapy cases, Zimmer Biomet says. The BioBoost Effect is the result of a proprietary combination of cancellous-like porosity and highly biocompatible tantalum.
Through enhanced gene expression, the effect prompts early bone healing and attachment with a two-week final loading protocol in appropriate cases, which has been documented to have a 97% to 100% survival rate after up to five years’ follow-up.
Clinical evidence also demonstrates the advantage of placing Trabecular Metal Implants in patients with risk factors such as diabetes, rheumatoid arthritis, prior oral infection, the effects of cancer treatment, and poor bone quality, Zimmer Biomet says.
And because the BioBoost Effect supports the healthy ingrowth of vascularized bone as well as the potential for enhanced bone healing compared to conventional titanium implants, Trabecular Metal Implants may have a clinical advantage when used in revision therapy, according to the company.
“Although Trabecular Metal Technology has been used successfully in orthopedic applications for more than 20 years, its role in dentistry has been undervalued until now. Today, we have a wealth of clinical evidence supporting its growing role in dental implant therapy,” said Indraneel Kanaglekar, vice president of global product management and R&D at Zimmer Biomet.
“Uncovering a scientific explanation for the body’s unique response to the Trabecular Metal Implant opens the door for our customers to treat a new subset of patients with a higher degree of confidence,” said Kanaglekar.
Related Articles
Partnership Donates Dental Implant Supplies to Veteran Outreach Program
Manufacturing Process Provides Implant Strength and Performance
Implants in the Aesthetic Zone: Clinical Guidelines
